HOME >> BIOLOGY >> NEWS
Impressive new Impact Factors for BioMed Central's open-access journals

Eleven journals published by BioMed Central, the open access publisher, received their first Impact Factor this month. With nine journals in the top 10 of their 2005 Journal Citation Report* category, and ten journals with a 2005 Impact Factor exceeding 3.00, open access journals are confirmed as publishing high-quality, highly cited research.

Genome Biology, BioMed Central's flagship title covering biology in the post-genomic era, has been assessed as having an Impact Factor of 9.71. The journal's first Impact Factor places it in the top five of research journals in the highly competitive Genetics and Heredity field, and the 4th most cited journal in the Biotechnology & Applied Microbiology. Matthew Cockerill, BioMed Central's Publisher, comments, "Genome Biology's impressive Impact Factor is evidence of BioMed Central's commitment to quality, and shows that top researchers at the cutting edge of biology are increasingly choosing open access publication for their best work."

Malaria Journal, with a first Impact Factor of 2.14, is the number two journal in the Tropical Medicine field, and number five in the Parasitology category. Launched in 2001, Malaria Journal was one of the first journals started as part of BioMed Central's independent journal program, and is the first of these independent journals to receive an Impact Factor.

Seven journals in the BMC series also received their first Impact Factors this year. BMC Developmental Biology, with an Impact Factor of 5.41, is ranked at number six in the developmental biology field. BMC Structural Biology enters the Biophysics category at number eight, with an Impact Factor of 5.00. BMC Evolutionary Biology's Impact Factor of 4.45 is the 6th most highly cited journal in the evolutionary biology category. BMC Biotechnology now has an Impact Factor of 3.05, BMC Neuroscience 2.73, BMC Microbiology 2.18, BMC Gastroenterology 1.46.

Dr Cockerill continues, "These impressive rankings demonstrat
'"/>

Contact: Grace Baynes
press@biomedcentral.com
44-207-631-9988
BioMed Central
20-Jun-2006


Page: 1 2

Related biology news :

1. Impact of forest certification in developing countries examined
2. Genome Biologys first Impact Factor 9.71
3. Factors affecting kernel yield in maize
4. BioMed Central announces new interdisciplinary Biofuels Journal
5. BioMed Central announces winners of first open access research awards
6. BioMed Central launches BMC Systems Biology, a new open access journal
7. BioMed Central launches Biology Direct
8. BioMed Central applauds Wellcomes leadership on Open Access
9. BioMed Central welcomes the new National Institutes of Health public access policy
10. BioMed Central announces publishing partnership with The Scientist magazine
11. Public Library of Science announces PLoS ONE: A new approach to open-access publishing

Post Your Comments:
(Date:6/14/2013)... GPS tracking collars to study hunting cheetahs in Botswana have ... village for a BBC programme. The BBC also deployed cat-cams ... the cat was moving. ,The Secret Life of The Cat, ... 2013 at 21:00., In a first study of its kind ... far they roamed and what they got up to once ...
(Date:6/14/2013)... Spain, 12 June 2013: Data presented at EULAR 2013, ... show that novel antibody biomarkers could significantly improve diagnosis ... UH-RA.1, UH-RA.9, UH-RA.14 and UH-RA.21 were investigated; ... and were present in both early and seronegative ... RF- and ACCP -negative patients testing positive. , ...
(Date:6/13/2013)... called "the microtubule network" is a crucial part ... transportation system within nerve cells, carrying essential proteins ... like Alzheimer,s, ALS, and Parkinson,s, this network breaks ... , Now Prof. Illana Gozes of Tel Aviv ... new peptide in her lab, called NAP or ...
Breaking Biology News(10 mins):From Botswanan big cats to Surrey house cats 2A peptide to protect brain function 2
(Date:6/15/2013)... The topics that will be covered in the ... roles, scrum meetings, scrum artifacts, and scrum simulation (optional). ... for attending them. , These trainings are suitable for ... is also ideal for those who will be a ... industry or those who want to explore Agile and ...
(Date:6/14/2013)... The OpenClinica Global Conference is ... year with Formedix CEO, Mark Wheeldon presenting as part ... a deeper insight into the future developments at OpenClinica ... Formedix to develop innovative solutions. , The conference program ... OpenClinica, hear real-life case studies and discover more about ...
(Date:6/14/2013)... SOUTH EASTON, Mass. , June 14, 2013 /PRNewswire/ ... today announced that it has closed the third and ... Convertible Preferred Stock and Warrants (the "Series J Private ... February 6 and $156,900 on March 28, 2013), the ... its Series J Private Placement, slightly over its goal ...
(Date:6/13/2013)... 2013 Eagle Biosciences is proud ... new Calprotectin ELISA assay kit that ... assay (1-2000 µg/g stool). The Calprotectin ELISA assay ... of human Calprotectin (neutrophil cytoplasmic protein s100A8/A9, MRP ... EagleBio’s gastrointestinal assay line which already includes Alpha ...
Breaking Biology Technology:Affordable Scrum Trainings in Chicago on July 12th 2013 by Conscires Agile Practices 2Affordable Scrum Trainings in Chicago on July 12th 2013 by Conscires Agile Practices 3Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 2Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 3Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 2Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 3Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 4Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 5Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit 2
Cached News: